Understanding Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC) - Episode 5

The Impact of Molecular Alterations in Advanced RAI-R-DTC Treatment Decision-Making

Lori Wirth, MD, explains why the importance of molecular alterations in her treatment decision-making for a patient with advanced RAI-R-DTC, and the other factors she considers for an appropriate treatment.